RBC Capital


What to Expect Ahead of Alibaba Group Holding Ltd’s First Quarter Earnings

RBC Capital analyst Mark Mahaney weighed in today with his views on Alibaba Group Holding Ltd (NYSE:BABA), as the Chinese e-commerce giant will likely report …

Analysts Confident in Fitbit Inc’s (FIT) Ability to Dominate Fitness Wearables Market

Fitbit Inc (NYSE:FIT) shares hit $42.15 yesterday, July 7, marking a 100% increase from its IPO price last month.

Battle of the Video Streaming Companies: Netflix, Inc. (NFLX) vs Amazon.com, Inc. (AMZN)

It’s fair to say that Netflix, Inc. (NASDAQ:NFLX) has single handedly created the video streaming market.

RBC Capital Pounds the Table on Pandora Media Inc (P)

RBC Capital analyst Mark Mahaney was out pounding the table on Pandora Media Inc (NYSE:P) Thursday, reiterating an Outperform rating and price target of $25, …

RBC Capital Maintains Positive View of Aerie Pharmaceuticals Inc Following FDA Agreement to Change Endpoint Range for Rhopressa

RBC Capital analyst Adnan Butt weighed in with some commentary on Aerie Pharmaceuticals Inc (NASDAQ:AERI) following an FDA agreement that the company may change the primary endpoint …

RBC Capital Pounds The Table On Facebook Inc (FB)

RBC Capital analyst Mark Mahaney was out pounding the table on Facebook Inc (NASDAQ:FB) Monday, reiterating an Outperform rating and price target of …

RBC Capital Pounds the Table on Regeneron Pharmaceuticals Inc

RBC Capital analyst Adnan Butt was out pounding the table with Regeneron Pharmaceuticals Inc (NASDAQ:REGN), reiterating an Outperform rating on the stock and boosting the price …

RBC Capital Maintains Outperform on Regeneron Pharmaceuticals Inc Following FDA Approval Recommendation for Praluent

RBC Capital analyst Adnan Butt came out with a research report on Regeneron Pharmaceuticals Inc (NASDAQ:REGN) following an FDA panel recommendation for the approval of Regeneron …

RBC Capital Cuts Price Target for Alibaba Group Holding Ltd Following Investor Conference

In a research report released after the market closed Tuesday, RBC Capital analyst Mark Mahaney reiterated an Outperform rating on Alibaba Group Holding Ltd (NYSE:BABA), while …

RBC Capital Weighs in on Biotech Stocks: Sarepta Therapeutics Inc (SRPT), PTC Therapeutics, Inc. (PTCT)

RBC Capital analyst Simos Simeonidis weighed in today on two biotech stocks, Sarepta Therapeutics Inc (NASDAQ:SRPT) and PTC Therapeutics, Inc. (NASDAQ:PTCT), following the release of the FDA Draft Document …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts